tert-Butyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetate, 95.0%, 10g

2-Amino-5-iodobenzoic Acid>98.0%(T)5g

7-chloro-4-fluoro-2H-indazole, 97%, 250mg

(6S)-6-[4-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane hydrochloride, 98%, 50mg

5,10,15,20-Tetrakis(4-aminophenyl)porphyrin>95.0%(HPLC)100mg

N,N-DIMETHYL(PIPERAZIN-2-YL)METHANAMINE, 95.0%, 250mg

3,4,5-Trimethoxybenzonitrile>98.0%(GC)5g

N,N-Bis(2-Hydroxyethyl)-4-pyridinecarboxamide, 250mg

Magnesium pellets 99.99% 4x4 mm 100 g

(R)-1-(4-Amino-1H-pyrazol-1-yl)propan-2-ol, 97%, 500mg

N-(2-Aminoethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95.0%, 1g

GC capillary column ROTI®Cap-5, 25 m, 0.53 mm, 0.50 µm, 1 Piece(s)

Tris(2,4-pentanedionato)iridium(III)1g